Meiji Seika, Toray sign license agreement for antipuritic agent

Japan |  News | 0 Comment | 25 Jan, 2019

Toray Industries, Inc. and Meiji Seika Pharma Co., Ltd. have announced that the companies have signed an exclusive license agreement on the orally disintegrating tablets formulation of anti...Read more

Nipro to use FlowForma to automate field processes

Japan |  News | 0 Comment | 24 Jan, 2019

FlowForma®, the leading provider of Process Automation tools for Microsoft Office 365®, has announced that Nipro Europe Group Companies will implement the award-winning FlowFor...Read more

Qiagen receives Japanese PMDA approval for cancer diagnostic kit

Japan |  News | 0 Comment | 24 Jan, 2019

QIAGEN N.V. recently announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic wi...Read more

Polyplastics develops new DURACON(R) POM PM Series for healthcare industry

Japan |  News | 0 Comment | 23 Jan, 2019

The Polyplastics Group has announced the development of the DURACON(R) polyoxymethylene (POM) PM series for drug contact and delivery applications for the medical/healthcare market. The new...Read more

Eisai listed as Global 100 most sustainable corporation

Japan |  News | 0 Comment | 22 Jan, 2019

Eisai Co., Ltd. has been listed in the 2019 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corpo...Read more

Mechanical stress may affect normal bone development

Japan |  News | 0 Comment | 21 Jan, 2019

The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsible for producing these materials. At early stages of development the...Read more

Thyas signs a licensing agreement with iPS-AJ

Japan |  News | 0 Comment | 18 Jan, 2019

Thyas has signed a licensing agreement with iPS Academia Japan, Inc. (iPS-AJ), a technology licensing organization of induced pluripotent stem (iPS) cell related-patents from Kyoto Universi...Read more

J&J completes acquisition of Ci:z Holdings

Japan |  News | 0 Comment | 18 Jan, 2019

Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase price of approximately ¥230 billion. The acquisition was completed...Read more

AIVITA gets IND nod for Phase 1B melanoma trial

Japan |  News | 0 Comment | 17 Jan, 2019

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New ...Read more

Daiichi Sankyo to lead open innovation research on cell therapy

Japan |  News | 0 Comment | 11 Jan, 2019

Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Tokyo Institute of Technology have announced that they will commence open innovation research with the aim of creating ...Read more

Japan approves Amgen's osteoporosis drug

Japan |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorization for EVENITY (romosozumab) for the treatment of osteoporosis in pa...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Japan |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for esaxerenone tablets, MINN...Read more

NapaJen Pharma closes $12.4M Series C financing

Japan |  News | 0 Comment | 09 Jan, 2019

NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery technology to develop novel immunotherapeutic agents, has announced ...Read more

Takeda completes acquisition of Shire

Japan |  News | 0 Comment | 08 Jan, 2019

Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven ...Read more

Fujifilm to invest 10B Yen in Bio CDMO biz

Japan |  News | 0 Comment | 08 Jan, 2019

FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in order to expand its Bio Contract Development and Manufacturing Organi...Read more

Solasia initiates Phase III programme for PledOx

Japan |  News | 0 Comment | 07 Jan, 2019

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Solasia acquired exclusive development and commercialization rights for ...Read more

Otsuka, Click Therapeutics to create therapy for mental illness

Japan |  News | 0 Comment | 07 Jan, 2019

Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therapeutics, Inc. (Click) have signed a collaboration agreement for Otsuka...Read more

Takeda announces multiple cell therapy collaborations

Japan |  News | 0 Comment | 04 Jan, 2019

Takeda Pharmaceutical  has announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus for the company. Through these collaborations, Takeda seeks to...Read more